PolyPeptide Group (Hangzhou) (revision 8)

PolyPeptide Group (Hangzhou) Co., Ltd. (trading as PPG; polypeptidegroup.net) is a solid-phase peptide synthesis operation trading as PPG from Hangzhou, Zhejiang, China, incorporated in 2006 and supplying research peptides and raw materials with batch documentation that reproduces the chromatogram behind each purity figure.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in Hangzhou in 2006, the organisation predates the current research-peptide market and describes a business built on solid-phase synthesis carried out on its own lines rather than on catalogue distribution.^[1] Hangzhou sits in the Yangtze River Delta manufacturing belt; the registry record establishes the entity and the date and nothing beyond them.^[1]

The organisation's own material describes in-house Fmoc solid-phase synthesis with purification and lyophilisation on site. That is a self-published characterisation and is recorded here as one: nothing available to this wiki establishes the manufacturing arrangements behind it, and a registered business scope is a licensing fact rather than a capability finding.^[2][1]

The documentary base is the registry record, the organisation's own material and purchaser-submitted test reports. No independent coverage has been identified, which is a characteristic of the sector rather than of this entity.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe vialled lyophilised material arriving with a batch-specific certificate naming a lot, and across the submitted set the lot string on the certificate has corresponded to the vial label and to the commercial documentation.^[5] That correspondence is a minimum requirement rather than an achievement, and it is recorded only because traceability fails often enough elsewhere in this sector to make its absence the more common finding.

The feature that distinguishes the submitted certificates from others held by this wiki is the reproduction of the chromatogram itself. Where a certificate ordinarily reports an area percent figure and asks the reader to accept it, the certificates in this set print the trace the figure was integrated from, with the gradient table, the column identifier and the detection wavelength beside it.^[5] A reader competent to read a chromatogram can therefore inspect baseline placement and integration limits rather than take the figure on trust. The limit of that is worth stating precisely: a printed trace evidences the integration of the injection it depicts. It does not establish that any particular vial was filled from the material that injection was drawn from, and no source available here bridges that gap.^[5]